|
Medical Devices and Prescription Drug Policy
|
|
|
|
|
May 16, 2013, 1:41 pm
By
Elise Viebeck
Drugs with ingredients derived from starch or grain would have to disclose those materials under a new Democratic bill, the Gluten in Medicine Disclosure Act.
Reps. Tim Ryan (D-Ohio) and Nita Lowey (D-N.Y.) introduced the measure to assist the roughly 3 million Americans with celiac disease, an autoimmune condition caused by a negative reaction to gluten.
"For millions of Americans, avoiding gluten is a medical necessity," said Lowey, top Democrat on the House Appropriations Committee, in a statement.
Read more...
Archived under:
Medical Devices and Prescription Drug Policy
|
May 15, 2013, 2:51 pm
By
Megan R. Wilson
A House panel on Wednesday advanced legislation along party lines to increase the tracking of prescription drugs.
The Safeguarding America's Pharmaceuticals Act of 2013 requires the Food and Drug Administration (FDA) to propose new rules to keep consumers safe from counterfeit prescriptions, but stops short of forcing regulators to finalize those rules.
Read more...
Archived under:
Medical Devices and Prescription Drug Policy, Legislation
|
May 13, 2013, 5:04 pm
By
Megan R. Wilson
Federal regulators issued the highest amount warning letters to medical device companies in 2012 than over the last seven years, according to a new study.
Read more...
Archived under:
Medical Devices and Prescription Drug Policy, Healthcare
|
May 13, 2013, 1:12 pm
By
Sam Baker
The federal government on Monday sought to block a judge's order requiring the agency to remove all age restrictions from the birth control pill known as Plan B. A lower court judge struck down age limits on the sale of Plan B, saying they were driven by politics rather than science. He gave the government until Monday to seek a delay from a higher court. The Justice Department filed a brief Monday requesting the delay, saying the lower court "plainly overstepped its authority."
Read more...
Archived under:
Medical Devices and Prescription Drug Policy
|
May 10, 2013, 11:40 am
By
Sam Baker
Judge Edward Korman refused to delay a ruling that made the birth-control pill available to girls of all ages.
Read more...
Archived under:
Medical Devices and Prescription Drug Policy
|
May 8, 2013, 10:36 am
By
Megan R. Wilson
Bipartisan legislation to give federal regulators the power to track individual medication moved forward in the House on Wednesday.
Read more...
Archived under:
Medical Devices and Prescription Drug Policy, Legislation
|
May 7, 2013, 5:00 pm
By
Sam Baker
A federal judge slammed the Food and Drug Administration on Tuesday over its handling of the birth-control pill known as Plan B. Judge Edward Korman accused the FDA of putting politics above science and described its regulation of Plan B as "a lot of nonsense," according to media reports. Korman ruled last month that the FDA must remove all age restrictions on the sale of Plan B. On Tuesday, he considered whether to stop his ruling from taking effect while the government pursues an appeal.
Read more...
Archived under:
Medical Devices and Prescription Drug Policy
|
May 6, 2013, 5:40 pm
By
Megan R. Wilson
Individuals using tanning beds may now face some sticker shock, as federal regulators will include stronger warnings of the potential health effects.
Read more...
Archived under:
Medical Devices and Prescription Drug Policy, Pending Regs
|
May 6, 2013, 4:51 pm
By
Julian Hattem
Some migraine medications can cause pregnant mothers to give birth to children with lower intelligence, the federal government is warning. The Food and Drug Administration (FDA) on Monday issued a warning that mothers who take some migraine drugs while pregnant can have children with lower IQ scores. Pregnant mothers should avoid medications containing and similar to the drug valproate sodium, the agency warns, including name brands Depakote and Depacon.
Read more...
Archived under:
Medical Devices and Prescription Drug Policy
|
May 3, 2013, 9:30 am
By
Elise Viebeck
Advocates angered by President Obama's morning-after pill policies
Big insurers wary of entering new ObamaCare markets
Catholic bishops condemn Irish abortion bill
Read more...
Archived under:
Medical Devices and Prescription Drug Policy
|